Plasminogen-Based Capture Combined with Amplification Technology for the Detection of PrPTSE in the Pre-Clinical Phase of Infection

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Segarra, Christiane ^a   Bougard, Daisy ^a   Moudjou, Mohammed ^b   Laude, Hubert ^b   Béringue, Vincent ^b   Coste, Joliette ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b INRA Institut National de la Recherche Agronomique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NANOBEAD; PLASMINOGEN; PRION PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BRAIN HOMOGENATE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LEUKOCYTE; MOUSE; NONHUMAN; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PRODUCT RECOVERY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; SCRAPIE; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; VARIANT CREUTZFELDT JAKOB DISEASE; WESTERN BLOTTING;

EID: 84880834921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069632     Document Type: Article

References (51)

1. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, et al. (1997) Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389: 498-501.
2. Institut National de Veille Sanitaire website available: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-declaration-obligatoire/Maladie-de-Creutzfeldt-Jakob/Donnees-epidemiologiques.Accessed 2012 August.
3. Bons N, Lehmann S, Mestre-Frances N, Dormont D, Brown P, (2002) Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus. Transfusion 42: 513-516.
4. Houston F, McCutcheon S, Goldmann W, Chong A, Foster J, et al. (2008) Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 112: 4739-4745.
5. McCutcheon S, Alejo Blanco AR, Houston EF, de Wolf C, Tan BC, et al. (2011) All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD. PLoS One 6: e23169.
6. Lacroux C, Bougard D, Litaise C, Simmons H, Corbiere F, et al. (2012) Impact of Leucocyte Depletion and Prion Reduction Filters on TSE Blood Borne Transmission. PLoS One 7: e42019.
7. Lacroux C, Vilette D, Fernandez-Borges N, Litaise C, Lugan S, et al. (2012) Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models. J Virol 86: 2056-2066.
8. Andreoletti O, Litaise C, Simmons H, Corbiere F, Lugan S, et al. (2012) Highly efficient prion transmission by blood transfusion. PLoS Pathog 8: e1002782.
9. Garske T, Ghani AC, (2010) Uncertainty in the tail of the variant Creutzfeldt-Jakob disease epidemic in the UK. PLoS One 5: e15626.
10. Collinge J, (2012) Cell biology. The risk of prion zoonoses. Science 335: 411-413.
11. HPA (2012) Health Protection Report. wwwhpaorguk/hpr/archives/2012/news3212htm.
12. Prusiner SB, (1998) Prions. Proc Natl Acad Sci U S A 95: 13363-13383.
13. Haley NJ, Mathiason CK, Carver S, Zabel M, Telling GC, et al. (2011) Detection of chronic wasting disease prions in salivary, urinary, and intestinal tissues of deer: potential mechanisms of prion shedding and transmission. J Virol 85: 6309-6318.
14. Notari S, Moleres FJ, Hunter SB, Belay ED, Schonberger LB, et al. (2010) Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. PLOS One 5: e8765.
15. Brown P, Cervenakova L, Diringer H, (2001) Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med 137: 5-13.
16. Saborio GP, Permanne B, Soto C, (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411: 810-813.
17. Castilla J, Saa P, Morales R, Abid K, Maundrell K, et al. (2006) Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 412: 3-21.
18. Castilla J, Saa P, Soto C (2004) Cyclic Amplification of Prion Protein Misfolding. In: Basel/Switzerland BV, editor. Techniques in Prion Research. 198-213.
19. Jones M, Peden AH, Prowse CV, Groner A, Manson JC, et al. (2007) In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol 213: 21-26.
20. Saa P, Castilla J, Soto C, (2006) Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 281: 35245-35252.
21. Soto C, Anderes L, Suardi S, Cardone F, Castilla J, et al. (2005) Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett 579: 638-642.
22. Thorne L, Terry LA, (2008) In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J Gen Virol 89: 3177-3184.
23. Tattum MH, Jones S, Pal S, Collinge J, Jackson GS, (2010) Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification. Transfusion 50: 996-1002.
24. Fischer MB, Roeckl C, Parizek P, Schwarz HP, Aguzzi A, (2000) Binding of disease-associated prion protein to plasminogen. Nature 408: 479-483.
25. Maissen M, Roeckl C, Glatzel M, Goldmann W, Aguzzi A, (2001) Plasminogen binds to disease-associated prion protein of multiple species. Lancet 357: 2026-2028.
26. Negredo C, Monks E, Sweeney T, (2007) A novel real-time ultrasonic method for prion protein detection using plasminogen as a capture molecule. BMC Biotechnol 7: 43.
27. Mays CE, Ryou C, (2010) Plasminogen stimulates propagation of protease-resistant prion protein in vitro. Faseb J 24: 5102-5112.
28. Langevin C, Andreoletti O, Le Dur A, Laude H, Beringue V, (2011) Marked influence of the route of infection on prion strain apparent phenotype in a scrapie transgenic mouse model. Neurobiol Dis 41: 219-225.
29. Beringue V, Le Dur A, Tixador P, Reine F, Lepourry L, et al. (2008) Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLOS One 3: e1419.
30. Laude H, Vilette D, Le Dur A, Archer F, Soulier S, et al. (2002) New in vivo and ex vivo models for the experimental study of sheep scrapie: development and perspectives. C R Biol 325: 49-57.
31. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, et al. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577-582.
32. Segarra C, Lehmann S, Coste J, (2009) Prion protein expression and processing in human mononuclear cells: the impact of the codon 129 prion gene polymorphism. PLOS One 4: e5796.
33. Castilla J, Saa P, Soto C, (2005) Detection of prions in blood. Nat Med 11: 982-985.
34. Saa P, Castilla J, Soto C, (2006) Presymptomatic detection of prions in blood. Science 313: 92-94.
35. Ellis V, Daniels M, Misra R, Brown DR, (2002) Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner. Biochemistry 41: 6891-6896.
36. Kornblatt JA, Marchal S, Rezaei H, Kornblatt MJ, Balny C, et al. (2003) The fate of the prion protein in the prion/plasminogen complex. Biochem Biophys Res Commun 305: 518-522.
37. Cuccioloni M, Amici M, Eleuteri AM, Biagetti M, Barocci S, et al. (2005) Binding of recombinant PrPc to human plasminogen: kinetic and thermodynamic study using a resonant mirror biosensor. Proteins 58: 728-734.
38. Rosi NL, Mirkin CA, (2005) Nanostructures in biodiagnostics. Chem Rev 105: 1547-1562.
39. Hall D, Minton AP, (2003) Macromolecular crowding: qualitative and semiquantitative successes, quantitative challenges. Biochim Biophys Acta 1649: 127-139.
40. Minton AP, (1998) Molecular crowding: analysis of effects of high concentrations of inert cosolutes on biochemical equilibria and rates in terms of volume exclusion. Methods Enzymol 295: 127-149.
41. Minton AP, (2001) The influence of macromolecular crowding and macromolecular confinement on biochemical reactions in physiological media. J Biol Chem 276: 10577-10580.
42. Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenk R, Alexeeva I, et al. (2011) Highly efficient protein misfolding cyclic amplification. PLOS Pathog 7: e1001277.
43. Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, et al. (2010) The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLOS Pathog 6: e1000859.
44. Nichols TA, Pulford B, Wyckoff AC, Meyerett C, Michel B, et al. (2009) Detection of protease-resistant cervid prion protein in water from a CWD-endemic area. Prion 3: 171-183.
45. Fujihara A, Atarashi R, Fuse T, Ubagai K, Nakagaki T, et al. (2009) Hyperefficient PrP Sc amplification of mouse-adapted BSE and scrapie strain by protein misfolding cyclic amplification technique. Febs J 276: 2841-2848.
46. Jones M, Peden AH, Yull H, Wight D, Bishop MT, et al. (2009) Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease. Transfusion 49: 376-384.
47. Cooper JK, Ladhani K, Minor P, (2012) Comparison of candidate vCJD in vitro diagnostic assays using identical sample sets. Vox Sang 102: 100-109.
48. Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, et al. (2011) Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 377: 487-493.
49. Orrú CD, Wilham JM, Raymond LD, Kuhn F, Schroeder B, et al. (2011) Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2: e00078-00011.
50. Soto C, (2004) Diagnosing prion diseases: needs, challenges and hopes. Nat Rev Microbiol 2: 809-819.
51. Chen B, Morales R, Barria MA, Soto C, (2010) Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat Methods 7: 519-520.